Myung In Pharmaceutical LTD. (KRX:317450)
South Korea · Delayed Price · Currency is KRW 43,300
+3,500 (8.79%)
At close: Jun 29, 2026
KRX:317450 Market Cap
KRX:317450 has a market cap or net worth of 606.63 billion as of June 30, 2026.
Market Cap
606.63B
Enterprise Value
85.82B
Revenue
289.14B
Ranking
n/a
PE Ratio
6.30
Stock Price
43,300.00
Market Cap Chart
Since October 1, 2025, KRX:317450's market cap has decreased from 1.78T to 606.63B, a decrease of -65.91%. That is a compound annual growth rate of -76.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 606.63B | -39.70% |
| Dec 30, 2025 | 1.01T | -43.48% |
| Oct 1, 2025 | 1.78T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.39T |
| Celltrion | 38.08T |
| ALTEOGEN | 19.98T |
| Samsung Epis Holdings | 10.70T |
| GI Innovation | 663.82B |
| Onconic Therapeutics | 635.71B |
| JW Pharmaceutical | 586.25B |
| Komipharm International | 562.10B |